Enlivex proposes reverse split as October 16 vote tests Enlivex stock
Published on 10/15/2026 at 12:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSReverse split and compliance timetable
- Shareholders will consider a 1-for-13 to 1-for-16 reverse split on October 16, 2026.
- Enlivex reported USD 1.89 billion in net income for the second quarter of 2026.
- Enlivex stock trades at EUR 0.19 at 12:33 p.m. CEST at Lang & Schwarz on October 15, 2026.
Enlivex (ISIN IL0011319527) was trading at EUR 0.19 at Lang & Schwarz on October 15, 2026, at 12:33 p.m. CEST. The company has scheduled a shareholder vote on a reverse split after its ordinary shares stayed below Nasdaq's USD 1.00 minimum bid requirement.
According to StockTitan, Enlivex amended its meeting materials on October 2, 2026. Shareholders will consider a first reverse split between 1-for-13 and 1-for-16, with the board authorized to choose the final ratio. The meeting is set for October 16, 2026, at 10:00 a.m. Israel time.
What does the split proposal change?
The proposed transaction would combine ordinary shares into a smaller number of shares rather than change each holder's ownership percentage. The filing says the board also seeks authority for additional reverse splits with an aggregate ratio between 1-for-2 and 1-for-1,000 during the following 12 months.
The compliance issue gives the vote immediate market relevance. Enlivex says its shares closed below USD 1.00 on each trading day from September 10, 2026, through the filing date. If the bid remains below that threshold for 30 consecutive trading days through October 21, 2026, Nasdaq could issue a staff delisting determination, according to StockTitan.
Three events shaped the setup
On July 30, 2026, Enlivex said Rain protocol trading volume reached USD 860.0 million in July, up 622.0 percent from June, according to the company's investor page. On September 22, 2026, the company announced termination of a previously announced financing payable in RAIN tokens, also shown on its investor page. On October 2, 2026, the amended filing moved the shareholder meeting to October 16, 2026, with the proposed split ratio set at 1-for-13 to 1-for-16.
Financial results add a sharp contrast
For the quarter ended June 30, 2026, Enlivex reported USD 1.89 billion in consolidated net income and a USD 4.23 million operating loss in the standardized financial data. A filing summary attributed the large net income figure primarily to unrealized digital-asset gains, leaving the operating result as the clearer measure of cash-consuming activity.
The next dated company event is the extraordinary meeting on October 16, 2026. The second date is October 21, 2026, when Nasdaq's 30-trading-day threshold would be reached if the bid remains below USD 1.00.
Stock price and listing risk
Enlivex was trading at EUR 0.19 at Lang & Schwarz on October 15, 2026, at 12:33 p.m. CEST. The price is shown without a daily comparison because a dated Xetra closing value for the last Xetra trading day could not be established.
The further course of trading is shown by the continuously updated real-time quote of Enlivex stock.
Enlivex stock key facts
- Company: Enlivex Ltd.
- ISIN: IL0011319527
- Ticker: ENLV
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 15, 2026, 12:33 p.m. CEST): EUR 0.19
- Sector / Industry: Healthcare / Biotechnology
Market context: Market report Nasdaq Composite.
